All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Antibody mix-up due to similar protein names may invalidate findings in over 300 cancer and aging studies

By

Mitch Leslie Mitch Leslie writes about cell biology and immunology.

6h ago· 6 min readenNews

Summary

A researcher has uncovered a widespread error in biomedical literature where hundreds of scientists studying cancer and aging mistakenly used antibodies targeting the wrong protein. Instead of antibodies for p16INK4a (a tumor-suppressing protein), researchers used antibodies for p16-ARC (a cytoskeleton protein). This mix-up, caused by confusingly similar protein names, appears in over 300 published papers, potentially undermining years of research on cancer and aging.

Key quotes

· 3 pulled
Hundreds of scientists who study cancer and aging have made an easily avoidable but significant mistake, deploying the wrong antibody to test for a key protein
Instead of antibodies that recognize p16INK4a, a tumor suppressing protein that may also promote aging, these researchers used antibodies that tag the similarly named protein p16-ARC, which helps shape the cell's molecular skeleton
The gaffe appears in more than 300 papers
Snippet from the RSS feed
Cancer and cell aging studies may have relied on antibodies to incorrect molecule

You might also wanna read